12:00 AM
Sep 13, 2010
 |  BC Week In Review  |  Clinical News  |  Regulatory

Abbott RealTime HBV assay regulatory update

FDA approved Abbott's RealTime HBV assay to measure HBV DNA levels to aid in managing patients with chronic HBV infection undergoing anti-viral therapy. The PCR...

Read the full 101 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >